---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-035636"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2025-04-25T23:59:59+00:00"
generated_at: "2026-05-23T06:05:20.559407+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Incannex receives Nasdaq bid price deficiency notice; cure period until Oct 20, 2025

## Summary
- Closing bid price of IXHL common stock below $1.00 for 30 consecutive trading days.
- Nasdaq granted 180-day compliance period ending October 20, 2025.
- If not compliant, Company may transfer to Nasdaq Capital Market for additional 180-day cure.
- Lead asset IHL-42X (obstructive sleep apnea) Phase 2 top-line data expected before end of H1 2025.
- Company evaluating options including reverse stock split to regain compliance.

## SEC filing metadata
- accession: 0001213900-25-035636
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2025-04-25T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390025035636/0001213900-25-035636-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390025035636/ea0239610-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-035636
- JSON: https://secwatch.observer/filing/0001213900-25-035636.json
- Plain text: https://secwatch.observer/filing/0001213900-25-035636.txt

## Key facts
- Listing & Compliance Notices
  Incannex Healthcare Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5810(c)(3)(A)
  source text: to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). This Notice is only a notification of a deficiency and has no immediate effect on the listing of the Company’s common stock, which continues to trade on The Nasdaq Global Market under the symbol “IXHL.” Pursuant to Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has been provided an initial period of 180 calendar days, or until October 20, 2025 (the “Compliance Date”), to regain compliance with the Bid Price Requirement. To regain compliance, the closing bid price of the Company’s Common Stock must m
  evidence_url: https://www.sec.gov/Archives/edgar/data/1873875/000121390025035636/0001213900-25-035636-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.